stem cell
[대역어] None
[용어속성] Term
[용어속성] Term
NSP4 and ORF9b of SARS-CoV-2 Induce Pro-Inflammatory Mitochondrial DNA Release in Inner Membrane-Derived Vesicles
Article
[키워드] airway epithelial cells
anti-apoptotic
approach
BCl2
BCL2 antagonist/killer
caused
cell death
cell-free mitochondrial DNA
changes
co-culture
co-cultured
COVID-19
COVID-19 patient
Effect
Effects
epithelial cells
functional
induce
inhibit
Inner
Interaction
intercellular
intercellular mitochondrial transfer
knockdown
MCL1
mechanism
membrane vesicle
mitigate
mitochondrial
mitochondrial DNA
Mortality
MSC
MSCs
myeloid cell
myeloid cell leukemia-1
nsp4
Orf9b
outer membrane
overexpression
plasma
pro-apoptotic
pro-inflammatory
Protein
Release
reversed
SARS-CoV-2
SARS-CoV-2 protein
screened
significantly
stem cell
therapeutic
Therapeutic approach
these cell
transfer
Treatment
tunneling nanotubes.
[DOI] 10.3390/cells11192969 PMC 바로가기
[DOI] 10.3390/cells11192969 PMC 바로가기
Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications
Article
[키워드] application
Autoimmune disease
Cell
Characteristics
chemokines
clinical
Clinical applications
Contact
contribute
COVID-19
Cytokines
disease
Diseases
Effect
Engineering
Factor
Growth factors
homing
immune
immune cells
immune disorders
Immune homeostasis
immune response
immunomodulation
immunomodulatory
immunomodulatory effect
immunomodulatory property
IMPROVE
incurable
Inflammatory diseases
Inflammatory responses
maintain
mechanism
mesenchymal stem cell
mesenchymal stem cells (MSCs).
MSC
MSCs
multifunctional
Potential
regenerative
Regulation
Secretome
shown
signaling molecules
STEM
stem cell
systemic lupus erythematosus
therapeutic strategy
treat
[DOI] 10.3390/ijms231710023 PMC 바로가기
[DOI] 10.3390/ijms231710023 PMC 바로가기
Mesenchymal stem cell treatment for hyperactive immune response in patients with COVID-19
COVID-19 환자의 과민성 면역 반응을 위한 중간엽 줄기세포 치료
Review
[키워드] Biomarker
Biomarkers
clinical
clinical immunology
clinical trials
COVID-19
COVID-19 mortality
COVID-19 patients
CRP
Cytokines
decrease
Effect
effective
Endothelitis
epithelial cells
Human immune system
IL-6
immune response
immune system
independent
invasive
mesenchymal stem cell
Mesenchymal stem cells
mesenchymal stem cells.
MSC
MSC therapy
MSCs
organism
patients with COVID-19
potential treatment option
pro-inflammatory cytokine
pro-inflammatory cytokines
PROTECT
reduction in
regenerative
regimen
reported
Respiratory failure
Safe
sick
stem cell
stem cells
systemic
systemic effects
therapy
Treatment
Trial
[DOI] 10.2217/imt-2021-0245 PMC 바로가기 [Article Type] Review
[DOI] 10.2217/imt-2021-0245 PMC 바로가기 [Article Type] Review
Stem cells, cell therapies, and bioengineering in lung biology and disease 2021
Article
[키워드] airway
Analysis
biennial
bioengineering
Biology
Cell
cells
cellular
college
COVID-19 pandemic
Cystic
differentiation
disease
Extracellular
Extracellular matrix
feature
foundation
heart
human lung
lung
Lung diseases
lung regeneration
lung tissues
Medicine
Microscopy
plasticity
pluripotent stem cells
pluripotent stem cells.
proteomics
recommendation
Regulation
remained
Research
Signaling
Society
STEM
stem cell
Therapies
translational
Treatment
University of Vermont
viral infection
[DOI] 10.1152/ajplung.00113.2022 PMC 바로가기
[DOI] 10.1152/ajplung.00113.2022 PMC 바로가기
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation
Article
[키워드] age
Allogeneic
allogeneic transplantation
antibody
Antibody Response
average
binding antibody unit
Blood donors
BNT162b2
chronic GVHD
CORD
COVID-19
detectable
Donor
dose
Efficacy
Graft-versus-host disease
GVHD
in vivo
independent predictor
initial
involved
JNJ-78436735
Johnson & Johnson
less
Lymphocyte count
lymphocyte counts
Moderna
mRNA-1273
multivariable analysis
Patient
Predictive
Prophylaxis
question
recipient
recipients
respond
response
robust
SARS-CoV-2 spike protein
SARS-CoV-2 vaccination
Serologic response
STEM
stem cell
Stem cell transplantation
T cell depletion
T-cell
T-cell Depletion
Transplant
transplantation
transplants
umbilical cord blood
vaccination
vaccination.
Vaccine
[DOI] 10.1016/j.jtct.2022.06.012 PMC 바로가기
[DOI] 10.1016/j.jtct.2022.06.012 PMC 바로가기
COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation
COVID-19 mRNA 부스터 백신은 일시적인 CD8+ T 효과기 세포 반응을 유도하는 동시에 후속 재활성화를 위해 메모리 풀을 보존합니다
Article
[키워드] activated
analyzed
boost
booster vaccination
Booster vaccine
Breakthrough infection
breakthrough infections
CD8
CD8+
Cell
conserved
COVID-19
COVID-19 vaccination
Delta
dose
effector cell
elicit
followed by
Immunity
immunization
individual
induce
memory
mRNA
mRNA vaccine
Neutralizing antibody response
neutralizing antibody responses
not affected
omicron
recall
receiving
response
robust
stem cell
subsequent
T cell
T cell response
T cell responses
T cells
T memory cells
vaccination
variants of concern
waning immunity
[DOI] 10.1038/s41467-022-32324-x PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41467-022-32324-x PMC 바로가기 [Article Type] Article
Stem cell-based therapy for human diseases
Reviews
[키워드] acute respiratory distress
adipose
Bone marrow
Brain
burns
candidate
cardiovascular conditions
Cell
cell type
cellular phenotype
clinical setting
clinical trial
contribute
defined
disease
Diseases
disorder
disorders
downstream
human disease
human diseases
Hypothesis
in vitro
ISCT
lineages
mechanism
MSC
MSCs
Neurological disorders
Patient
pluripotent stem cell
progenitor cell
provide
pulmonary disease
recent
regenerative
reproductive
Research
Society
Spinal cord injury
STEM
stem cell
Support
syndrome
targeted therapy
therapy
tissue
translational
treated
Treatment
UC-MSC
umbilical
[DOI] 10.1038/s41392-022-01134-4 [Article Type] Reviews
[DOI] 10.1038/s41392-022-01134-4 [Article Type] Reviews
SARS-CoV-2 infection impairs the insulin/IGF signaling pathway in the lung, liver, adipose tissue, and pancreatic cells via IRF1
SARS-CoV-2 감염은 IRF1을 통해 폐, 간, 지방 조직 및 췌장 세포의 인슐린/IGF 신호 전달 경로를 손상시킵니다
Article
Published on
Journal: Metabolism: clinical and experimental
[Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘,
Journal: Metabolism: clinical and experimental
[Category] COVID19(2023년), SARS, 변종, 유전자 메커니즘,
[키워드] Activation
adeno-associated virus
adipose
Adipose tissue
AKT
ameliorated
analyzed
association
Autopsy
Calu3
Calu3 cell
CaLu3 cells
Cell
cell survival
cells
condition
contribute
COVID-19
COVID-19 pathology
COVID-19 patient
COVID-19 patients
COVID-19 severity
Critical
critical patient
critical patients
cytokine
determine
Dexamethasone
diabetes
Diabetic
diabetic patients
Dihydrotestosterone
Endocrine
energy metabolism
European population
evaluate
Evidence
exacerbated
exhibited
Gain
Gene Expression
Genes
GFP
HEK293T
Hospitalized
Host
human ACE2
human cells
hyperglycemia
impair
impairment
infected with SARS-CoV-2
insulin
insulin resistance
Insulin signaling
Insulin/IGF signaling pathway
interferon regulatory factor
Interferone
intron
IRF1
liver
lung
Lungs
male
Male sex
MAPK
metabolic
metabolic abnormalities
Metabolic abnormality
metabolism
mouse model
mTOR
Multiorgan dysfunction
Multiple organ damage
Non-COVID-19
Non-COVID-19 patients
obese
obesity
Older
Older age
Organoid
overexpressing
pancreatic
Pancreatic cell
pancreatic islets
pathology
patients
patients with COVID-19
PI3K
potential mechanism
Prevalence
provide
Regulation
reported
Repository
risk factor
Risk factors
SARS-CoV-2
SARS-CoV-2 infected cell
SARS-CoV-2 infected cells
SARS-COV-2 infection
serotype
severe COVID-19
severity
Signaling
signaling pathway
significantly
stem cell
survival
tissue
tissue damage
Tissue damage.
tissues
Transcriptome
transcriptome dataset
transcriptome datasets
Transgenic mouse
variant
Whole blood
whole blood transcriptome
with COVID-19
[DOI] 10.1016/j.metabol.2022.155236 PMC 바로가기 [Article Type] Article
[DOI] 10.1016/j.metabol.2022.155236 PMC 바로가기 [Article Type] Article
Tissue repair strategies: What we have learned from COVID-19 in the application of MSCs therapy
Review article
[키워드] ACE2angiotensin converting enzyme 2
acute lung injury
acute respiratory distress syndrome
adverse outcome
ALIacute lung injury
alveolar type 2 cells
angiotensin converting enzyme 2
ARDSacute respiratory distress syndrome
AstraZeneca
AT2salveolar type 2 cells
ataxia telangiectasia and Rad3-related
ATRataxia telangiectasia and Rad3-related
BDNFbrain derived neurotrophic factor
brain derived neurotrophic factor
BRDbromodomain protein
bromodomain protein
C-reactive protein
CCNG1Cyclin G1
CD147cluster of differentiation 147
Cell
Clinical finding
cluster of differentiation 147
confirmed case
Coronavirus disease 2019
COVID-19
COVID-19 pandemic
COVID-19 patients
COVID-19coronavirus disease 2019
CRPC-reactive protein
Cyclin G1
Cytokine storm
DRP1dynamin-related protein 1
dynamin-related protein 1
ECMOextracorporeal membrane oxygenation
effective
EGFepidermal growth factor
Emergency use authorization
epidermal growth factor
EUAemergency use authorization
EVsextracellular vesicles
example
exhibited
Extracellular vesicles
extracorporeal membrane oxygenation
FGFfibroblast growth factor
fibroblast growth factor
galanin and gmap prepropeptide
GALgalanin and gmap prepropeptide
GM-CSFgranulocyte macrophage-colony stimulating factor
granulocyte macrophage-colony stimulating factor
HBVHepatitis B virus
Heme oxygenase-1
Hepatitis B virus
hepatocyte growth factor
hESCshuman embryonic stem cells
HGFhepatocyte growth factor
hiPSCshuman induced PSCs
HIVhuman immunodeficiency virus
HO-1heme oxygenase-1
hPSC-CMshPSC-derived cardiomyocytes
hPSC-derived cardiomyocytes
hPSCshuman pluripotent stem cells
human embryonic stem cells
Human immunodeficiency virus
human induced PSCs
human pluripotent stem cells
Hyperinflammatory syndrome
IFN-βinterferon-β
IFN-γinterferon-γ
IFN-λinterferon-λ
IGF1Rinsulin like growth factor 1 receptor
Infection
insulin like growth factor 1 receptor
Intensive
Interferon-β
interferon-γ
interferon-λ
keratinocyte growth factor-2
KGF2keratinocyte growth factor-2
leukemia inhibitory factor
LIFleukemia inhibitory factor
management
MECP2methyl-CpG binding protein 2
Mesenchymal stem cells
methyl-CpG binding protein 2
Microvesicles
Moderna
Mortality
MSCs
MSCs therapy
MSCsmesenchymal stem cells
MVsmicrovesicles
National Institutes of Health
nerve growth factor
NGFnerve growth factor
NIHNational Institutes of Health
nitric oxide associated 1
NLR family pyrin domain containing 3
NLRP3NLR family pyrin domain containing 3
NOA1nitric oxide associated 1
organ damage
organ injury
P4HA1prolyl 4-hydroxylase subunit alpha 1
PDGFplatelet-derived growth factor
Pfizer
PGE2prostaglandin E2
phosphatase and tensin homolog
platelet-derived growth factor
Preclinical
Preferred reporting items for systematic reviews and meta-analyses
PRISMAPreferred reporting items for systematic reviews and meta-analyses
proinflammatory
prolyl 4-hydroxylase subunit alpha 1
prostaglandin E2
PTENphosphatase and tensin homolog
Pulmonary infection
Randomized controlled trial
RCTrandomized controlled trial
S-proteinspike protein
SARS-CoV-2severe acute respiratory syndrome coronavirus 2
SEMA3Asemaphorin 3 A
semaphorin 3 A
severe acute respiratory syndrome coronavirus 2
sialyl Lewis X
signal transducer and activator of transcription 3
SLeXsialyl Lewis X
Spike protein
spread of COVID-19
STAT3signal transducer and activator of transcription 3
stem cell
TGF-β1transforming growth factor β1
TGFBR1transforming growth factor β receptor I
Therapies
therapy
tissue regeneration
TLR4toll-like receptors 4
TMPRSS2transmembrane protease serine protease 2
TNFTumor Necrosis Factor
toll-like receptors 4
transforming growth factor β receptor I
transforming growth factor β1
transmembrane protease serine protease 2
tumor necrosis factor
utility
Vaccine
Vaccines
vascular cell adhesion molecule
vascular endothelial growth factor
VCAMvascular cell adhesion molecule
VEGFvascular endothelial growth factor
[DOI] 10.1016/j.phrs.2022.106334 [Article Type] Review article
[DOI] 10.1016/j.phrs.2022.106334 [Article Type] Review article